Abstract
Polo-like kinase (Plk) 1 is a serine-threonine protein kinase that plays a role in cell division, and its overexpression is highly correlated with aggressiveness and prognosis of many cancers. We have designed, synthesized and evaluated a series of terphenyl compounds as inhibitors of the kinase activity of Plk1. Some of them act as non-ATP-competitive Plk1 inhibitors.
Original language | English |
---|---|
Pages (from-to) | 608-617 |
Number of pages | 10 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 21 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2013 Feb 1 |
Externally published | Yes |
Keywords
- Inhibitor
- Non-ATP-competitive
- Non-peptide
- Polo-like kinase
- Small molecule
- Terphenyl skeleton
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry